A Biotechnology Start Up Approach to Developing Medicines for Animal Health

Add to your list(s) Download to your calendar using vCal

• Simon Aspland, General Manager Acidophil Ltd, VP Business Development
• Wednesday 15 February 2017, 16:00-17:00
• Lecture Theatre 2, Department of Veterinary Medicine.

If you have a question about this talk, please contact Fiona Roby.

Acidophil is a biotechnology innovation and commercialization company that semi-serially creates, manages and commercializes new biotechnology products and businesses serving health and agriculture. Recently, Acidophil co-founded AgriMetis with Syngenta Ventures as an “external innovator” to develop novel products and methods to manufacture products for crop protection. This talk aims to provide an overview of the process used by Acidophil to develop new opportunities, explore lessons learnt from building AgriMetis that may be applicable to a new venture focused on medicines for animal health and illustrate ways in which parties interested in veterinary medicine could work with Acidophil.

This talk is part of the Departmental Seminar Programme, Department of Veterinary Medicine series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• Cambridge Immunology
• Cambridge Infectious Disease
• Cambridge Infectious Diseases
• Departmental Seminar Programme, Department of Veterinary Medicine
• Lecture Theatre 2, Department of Veterinary Medicine
• Vet School Seminars

Note that ex-directory lists are not shown.